Does CPAP lead to change in BMI?

Journal of Clinical Sleep Medicine

Volumn 4, Issue 3, 2008, Pages 205-209

  Redenius, Rachel ^a   Murphy, Carli ^a   O'Neill, Erin ^a   Al Hamwi, Majed ^b   Zallek, Sarah Nath ^a,b  

^a Illinois Neurological Institute   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

BMI; CPAP; Obesity; OSA; OSAS; Sleep disordered breathing; Weight loss

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SLEEP APNEA SYNDROME; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 47849090893     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.27181     Document Type: Article

References (18)

1. Young T, Palta M, Dempsey J, Skatrud J. Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5.
2. Aldrich MS. Sleep medicine. Oxford: Oxford University Press, 1999.
3. Novak M, Mendelssohn D, Shapiro CM. Mucsi I. Diagnosis and management of sleep apnea syndrome and restless legs syndrome in dialysis patients. Semin Dial 2006;19:210-6.
4. Palmer LJ, Buxbaum SG, Larkin E, et al. A whole-genome scan for obstructive sleep apnea and obesity. Am J Hum Genet 2003;72:340-50.
5. Gami AS, Caples SM, Somers VK. Obesity and obstructive sleep apnea. Endocrinol Metab Clin North Am 2003;32:869-94.
6. O'Donnell CP, Tankersley CG, Polotsky VP, Schwartz AR, Smith PL. Leptin, obesity, and respiratory function. Respir Physiol 2000;119:173-80.
7. Fitzpatrick M. Leptin and the obesity hypoventilation syndrome: a leap of faith? Thorax 2002;57:1-2.
8. Spiegel K, Leproult R, L'Hermite-Balériaux M, Copinschi G, Penev PD, Van Cauter E. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endocrinol Metab 2004;89:5762-71.
9. Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004;141:846-50.
10. Hui DSC, Choy DKL, Li TST, et al. Determinants of continuous positive airway pressure compliance in a group of chinese patients with obstructive sleep apnea. Chest 2001;120:170-6.
11. Loube DI, Loube AA, Erman MK. Continuous positive airway pressure treatment results in weight loss in obese and overweight patients with obstructive sleep apnea. J Am Diet Assoc 1997;97:896-7.
12. Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999;100:706-12.
13. Harsch IA, Konturek PC, Koebnick C, et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 2003;22:251-7.
14. Kuczmarski RJ. Prevalence of overweight and weight gain in the United States. Am J Clin Nutr 1992;55:495S-502S.
15. Grunstein R. Endocrine disorders. In: Kryger MH, Roth T, Dement WC. Principles and practices of sleep medicine. 4th ed. Philedephia: Elsevier Saunders, 2005:1242-3.
16. Kajaste S, Brander PE, Telakivi T, Partinen M, Mustajoki P. A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med 2004;5:125-31.
17. Hensrud DD, Klein S. Extreme obesity: a new medical crisis in the United States. Mayo Clin Proc 2006;81:S5-10.
18. Stenlof K, Grunstein R, Hedner J, Sjostrom L. Energy expenditure in obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Am J Physiol 1996;271:E1036-43.